ACM
BIIB icon

Advisors Capital Management’s Biogen BIIB Stock Holding History

Advisors Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$220K Buy
+1,020
New +$195K ﹤0.01% 592
2024
Q3 		– Sell
-1,130
Closed -$262K – 495
2024
Q2 		$262K Buy
1,130
+29
+3% +$6.3K ﹤0.01% 435
2024
Q1 		$237K Sell
1,101
-146
-12% -$34.2K ﹤0.01% 441
2023
Q4 		$323K Buy
1,247
+176
+16% +$43.2K 0.01% 393
2023
Q3 		$275K Buy
+1,071
New +$286K 0.01% 363

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Advisors Capital Management's BIIB Position: Q2 2026 in Review

Advisors Capital Management opened a new position in Biogen (BIIB) in Q2 2026: 1,020 shares worth $220K. The stake represents ﹤0.01% of the portfolio and ranks #592 among its holdings. This is a return to the name: Advisors Capital Management previously reported a position in BIIB as recently as Q2 2024.

Advisors Capital Management first reported a position in BIIB in Q3 2023 and has held it in 5 quarters since. The position peaked at $323K in Q4 2023. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Advisors Capital Management held 1,020 shares of Biogen worth $220K as of Q2 2026.
  • Biogen was a new Advisors Capital Management position in Q2 2026.
  • Biogen made up ﹤0.01% of Advisors Capital Management's portfolio in Q2 2026, its #592 holding.
  • Advisors Capital Management first reported a position in Biogen in Q3 2023 and has held it in 5 quarters since.
  • Advisors Capital Management's Biogen position peaked at $323K in Q4 2023.
  • 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Advisors Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.